Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quetiapine in Schizophrenia and Substance Use Disorder
NCT00156715Phase 4Completed
- Sponsor
- Dartmouth Health
- Start
- Mar 2004
- Primary completion
- Sep 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of quetiapine in schizophrenia, schizoaffective disorder, substance use disorder (SUD), alcohol use disorder (AUD), sponsored by Dartmouth Health. Started Mar 2004; status: completed.
02
Drugs
quetiapine
03
Conditions
schizophreniaschizoaffective disordersubstance use disorder (SUD)alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT00156715.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00156715.